Agenda

February 7-9, 2025 | Fontainebleau Miami Beach

Register Now

Friday February 07, 2025

  • 12:00 PM – 1:00 PM

    Innovation Theatre/Symposium (Non-Accredited)

  • +
    1:00 PM – 3:00 PM

    Leukemia Landscape: Research and Clinical Advances (Part 1)

    • 1:00 PM – 1:20 PM
      Updates in the Diagnosis and Classification of Myeloid Malignancies
    • 1:20 PM – 1:40 PM
      Updates in Low/Intermediate Risk Myelodysplastic Syndromes
    • 1:40 PM – 2:00 PM
      Updates in High-Risk Myelodysplastic Syndromes
    • 2:00 PM – 2:20 PM
      Updates in Chronic Myeloid Leukemia
    • 2:20 PM – 2:40 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 2:40 PM – 3:00 PM
      Questions & Answers
  • 3:00 PM – 3:10 PM

    Break

  • +
    3:10 PM – 5:10 PM

    Leukemia Landscape: Research and Clinical Advances (Part 2)

    • 3:10 PM – 3:30 PM
      Updates in Myeloproliferative Neoplasms
    • 3:30 PM – 3:50 PM
      Updates in Acute Lymphoblastic Leukemia
    • 3:50 PM – 4:10 PM
      Updates in Front Line Acute Myeloid Leukemia
    • 4:10 PM – 4:30 PM
      Updates in Relapsed Acute Myeloid Leukemia
    • 4:30 PM – 4:50 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 4:50 PM – 5:10 PM
      Questions & Answers
  • 5:10 PM – 5:15 PM

    Break

  • 5:15 PM – 6:15 PM

    Innovation Theatre/Symposium (Non-Accredited)

  • 6:15 PM – 7:15 PM

    Welcome Reception & Networking

Saturday February 08, 2025

  • 8:00 AM – 9:00 AM

    Innovation Theatre/Symposium (Non-Accredited)

  • +
    9:00 AM – 11:00 AM

    CLL Landscape: Research and Clinical Advances

    • 9:00 AM – 9:20 AM
      Updates in New Classifications and Risk Stratifications
    • 9:20 AM – 9:40 AM
      Updates in Bispecific Antibodies, Degraders, CAR-T Cells
    • 9:40 AM – 10:00 AM
      Updates in BTKi + BCL2 Therapy in the Retreatment Population
    • 10:00 AM – 10:20 AM
      Updates in the Management of BTK Resistance & Mutations
    • 10:20 AM – 10:40 AM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 10:40 AM – 11:00 AM
      Questions & Answers
  • 11:00 AM – 11:10 AM

    Break

  • +
    11:10 AM – 1:10 PM

    Multiple Myeloma Landscape: Research and Clinical Advances (Part 1)

    • 11:10 AM – 11:30 AM
      Updates in basic science, pathophysiology, and diagnosis (including MRD & P53)
    • 11:30 AM – 11:50 AM
      Updates in Precursor Disorders
    • 11:50 AM – 12:10 PM
      Updates in Front Line – Transplant Eligible Multiple Myeloma
    • 12:10 PM – 12:30 PM
      Updates in Front Line – Transplant Ineligible Multiple Myeloma
    • 12:30 PM – 12:50 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 12:50 PM – 1:10 PM
      Questions & Answers
  • 1:10 PM – 2:10 PM

    Innovation Theatre/Symposium (Non-Accredited)

  • 2:10 PM – 2:40 PM

    Exhibit Hall Break

  • +
    2:40 PM – 4:40 PM

    Multiple Myeloma Landscape: Research and Clinical Advances (Part 2)

    • 2:40 PM – 3:00 PM
      Updates in Relapsed Disease
    • 3:00 PM – 3:20 PM
      Updates in Relapsed or Refractory CAR-T Therapy
    • 3:20 PM – 3:40 PM
      Updates in Relapsed or Refractory Bispecific Antibody Treatment
    • 3:40 PM – 4:00 PM
      Updates in Relapsed or Refractory Novel Agents
    • 4:00 PM – 4:20 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 4:20 PM – 4:40 PM
      Questions & Answers
  • 4:40 PM – 4:45 PM

    Break

  • 4:45 PM – 5:45 PM

    Innovation Theatre/Symposium (Non-Accredited)

  • 5:45 PM – 7:15 PM

    Exhibit Hall & Grand Reception

Sunday February 09, 2025

  • 8:00 AM – 9:00 AM

    Innovation Theatre/Symposium (Non-Accredited)

  • +
    9:00 AM – 11:00 AM

    Lymphoma Landscape: Research and Clinical Advances (Part 1)

    • 9:00 AM – 9:20 AM
      Updates in Basic Science, Pathophysiology, and Diagnosis (including MRD, P53 & cDNA)
    • 9:20 AM – 9:40 AM
      Updates in Frontline Treatment of Diffuse Large B-Cell Lymphoma
    • 9:40 AM – 10:00 AM
      Updates in Relapsed Diffuse Large B-Cell Lymphoma
    • 10:00 AM – 10:20 AM
      Updates in Mantle Cell Lymphoma and Marginal Zone Lymphoma
    • 10:20 AM – 10:40 AM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 10:40 AM – 11:00 AM
      Questions & Answers
  • 11:00 AM – 12:00 PM

    Innovation Theatre/Symposium (Non-Accredited)

  • +
    12:00 PM – 2:00 PM

    Lymphoma Landscape: Research and Clinical Advances (Part 2)

    • 12:00 PM – 12:20 PM
      Updates in Frontline Treatment of Follicular Lymphoma
    • 12:20 PM – 12:40 PM
      Updates in Treatment of Relapsed Follicular Lymphoma
    • 12:40 PM – 1:00 PM
      Updates in Hodgkin Lymphoma
    • 1:00 PM – 1:20 PM
      Updates in Other Clinical Presentations (CNS, PTCL)
    • 1:20 PM – 1:40 PM
      From Data to Impact: Improving Clinical Decisions (Patient Case Presentation & Discussion)
    • 1:40 PM – 2:00 PM
      Questions & Answers